Announcement of transactions with shares and linked securities in H.
Lundbeck A/S made by executives and their closely associated persons
and legal entities
H. Lundbeck A/S hereby reports transactions made by executives and
persons and legal entities closely associated to them with shares in
H. Lundbeck A/S and linked securities, cf. section 28a of the Danish
Securities Trading Act.
The list is based on reports received by H. Lundbeck A/S from the
company's executives today or yesterday.
+-------------------------------------------------------------------+
| Name: | Claus Bræstrup |
| | |
|--------------------------------+----------------------------------|
| Job position of the executive: | CEO |
| | |
|--------------------------------+----------------------------------|
| Relation to executive | |
| (associated person or legal | |
| entity): | |
| | |
|--------------------------------+----------------------------------|
| ID code (ISIN code): | DK 0010287234 |
| | |
|--------------------------------+----------------------------------|
| Description of the security: | Warrant |
| | |
|--------------------------------+----------------------------------|
| Nature of the transaction: | Exercise of warrant (purchase of |
| | shares) |
|--------------------------------+----------------------------------|
| Date of trading: | 27 August 2007 |
| | |
|--------------------------------+----------------------------------|
| Market on which the trading | Copenhagen Stock Exchange |
| was effected: | |
| | |
|--------------------------------+----------------------------------|
| Number of traded securities: | 40.000 | pcs. |
| | | |
|--------------------------------+---------------+------------------|
| Market price of securities | DKK | 4.324.400 |
| traded: | | |
| | | |
+-------------------------------------------------------------------+
+-------------------------------------------------------------------+
| Name: | Stig Løkke Pedersen |
| | |
|---------------------------------------+---------------------------|
| Job position of the executive: | EVP |
| | |
|---------------------------------------+---------------------------|
| Relation to executive (associated | |
| person or legal entity): | |
| | |
|---------------------------------------+---------------------------|
| ID code (ISIN code): | DK 0010287234 |
| | |
|---------------------------------------+---------------------------|
| Description of the security: | Warrant |
| | |
|---------------------------------------+---------------------------|
| Nature of the transaction: | Exercise of warrant |
| | |
|---------------------------------------+---------------------------|
| Date of trading: | 27 August 2007 |
| | |
|---------------------------------------+---------------------------|
| Market on which the trading was | Copenhagen Stock Exchange |
| effected: | |
| | |
|---------------------------------------+---------------------------|
| Number of traded securities: | 7.500 | pcs. |
| | | |
|---------------------------------------+------------+--------------|
| Market price of securities traded: | DKK | 810.825 |
| | | |
+-------------------------------------------------------------------+
Persons/entities under an obligation to report
Persons or entities under an obligation to report are defined as
members of the Executive Management and the Supervisory Board of H.
Lundbeck A/S and persons/entities closely associated to them.
Closely associated persons/entities means inter alia:
* spouse or cohabitant
* children below the age of 18
* legal entities in which the insider has a controlling influence
The content of this release will have no influence on the Lundbeck
Group's financial result for 2007.
Lundbeck contacts
Investors: Media:
Jacob Tolstrup Caroline Broge
Director, Investor Relations Media Relations Manager
+45 36 43 30 79 +45 36 43 26 38
+1 201 350 0187
________________________
Stock Exchange Release No 288 - 27 August 2007
About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com
